跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEVA-BUPROPION XL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TEVA-BUPROPION XL
Authorized
STANDARD
TEVA-BUPROPION XL
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
1613f567761edb04
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
1613f567761edb04
Drug Approval Canada Name
TEVA-BUPROPION XL
Product Name
TEVA-BUPROPION XL
Status
Marketed
Status Date
2020-05-28
Original Market Date
2016-05-03
Din
02439654
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.92
Atc Original
N06AX12 BUPROPION
Atc Name
n 06 ax 12
Aig Number
0131140003
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
BUPROPION HYDROCHLORIDE
150 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
1613f567761edb04
Type
Standard
Back to Health Canada Approvals